FONAR Corp (FONR)
NASDAQHealth CareMedical - Equipment & ServicesSnapshot 2026-09-04
$19.090.00%
Close 2026-06-05 · 1-day change
NASDAQHealth CareMedical - Equipment & ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · FONR
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $19 FONR trades at 18× p/e, below its 27× p/e peer median. Our $35 fair value sits above the price; high confidence. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| Peer EV/EBITDA | 12M | $39.00 | 11.0 | 2.88 | TTM | high |
| Peer P/FCF | 12M | $18.03 | 27.5 | 0.66 | TTM | high |
| Peer P/E | 12M | $28.56 | 27.0 | 1.06 | TTM | high |
| Peer P/S | 12M | $57.01 | 3.8 | 15.17 | TTM | high |
| Peer P/FCF | 3Y |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Only weak execution quality, a turbulent sector regime (Heating) — not the full expensive x weak x turbulent stack.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Not enough peers to compare yet.
Self-history needs ~20 months of data.
Trailing four: 2022-Q3, 2023-Q1, 2023-Q2, 2023-Q3
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $7.33 |
| 27.5 |
| 0.27 |
| Hist. CAGR(prov.) |
| low |
| Peer P/S | 3Y | $61.31 | 3.8 | 16.31 | Hist. CAGR(prov.) | low |
| Peer P/FCF | 5Y | $4.02 | 27.5 | 0.15 | Hist. CAGR(prov.) | low |
| Peer P/S | 5Y | $64.36 | 3.8 | 17.12 | Hist. CAGR(prov.) | low |